Literature DB >> 20801557

The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.

Zhu-Ping Xiao1, Tao-Wu Ma, Wei-Chang Fu, Xiao-Chun Peng, Ai-Hua Zhang, Hai-Liang Zhu.   

Abstract

Some pyrogallol and catechol derivatives were synthesized, and their urease inhibitory activity was evaluated by using acetohydroxamic acid (AHA), a well known Helicobacter pylori urease inhibitor, as positive control. The assay results indicate that many compounds have showed potential inhibitory activity against H. pylori urease. 4-(4-Hydroxyphenethyl)phen-1,2-diol (2a) was found to be the most potent urease inhibitor with IC(50)s of 1.5±0.2 μM for extracted fraction and 4.2±0.3 μM for intact cell, at least 10 times and 20 times lower than those of AHA (IC(50) of 17.2±0.9 μM, 100.6±13 μM), respectively. This finding indicate that 2a would be a potential urease inhibitor deserves further research. Molecular dockings of 2a into H. pylori urease active site were performed for understanding the good activity observed.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20801557     DOI: 10.1016/j.ejmech.2010.08.015

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  12 in total

1.  Bis(aminomethyl)phosphinic Acid, a Highly Promising Scaffold for the Development of Bacterial Urease Inhibitors.

Authors:  Katarzyna Macegoniuk; Anna Dziełak; Artur Mucha; Łukasz Berlicki
Journal:  ACS Med Chem Lett       Date:  2014-12-11       Impact factor: 4.345

2.  Antimicrobial and antiurease activities of newly synthesized morpholine derivatives containing an azole nucleus.

Authors:  Hakan Bektaş; Sule Ceylan; Neslihan Demirbaş; Sengül Alpay-Karaoğlu; Bahar Bilgin Sökmen
Journal:  Med Chem Res       Date:  2012-11-29       Impact factor: 1.965

3.  7-Meth-oxy-3-(4-meth-oxy-phen-yl)chroman-4-one.

Authors:  Zhi-Yun Peng; Xiao-Yang Liu; Ye-Ling Yang; Kai-Shuang Xiang; Zhu-Ping Xiao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-01-07

4.  3-(4-Hy-droxy-phen-yl)-7-meth-oxy-chroman-4-one monohydrate.

Authors:  Zhu-Ping Xiao; Zhu-Yun Peng; Qun Luo; Ying Wu; Ye-Ling Yang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-11-05

5.  A high-throughput visual screening method for p-hydroxybenzoate hydroxylase to increase phenolic compounds biosynthesis.

Authors:  Zhenya Chen; Tongtong Chen; Shengzhu Yu; Yi-Xin Huo
Journal:  Biotechnol Biofuels Bioprod       Date:  2022-05-02

6.  Antibacterial, antiurease, and antioxidant activities of some arylidene barbiturates.

Authors:  Bahar Bilgin Sokmen; Serpil Ugras; Hasan Yucel Sarikaya; Halil Ibrahim Ugras; Refiye Yanardag
Journal:  Appl Biochem Biotechnol       Date:  2013-09-11       Impact factor: 2.926

Review 7.  A review on the development of urease inhibitors as antimicrobial agents against pathogenic bacteria.

Authors:  Yuri F Rego; Marcelo P Queiroz; Tiago O Brito; Priscila G Carvalho; Vagner T de Queiroz; Ângelo de Fátima; Fernando Macedo
Journal:  J Adv Res       Date:  2018-05-04       Impact factor: 10.479

8.  Anti-Influenza Virus (H5N1) Activity Screening on the Phloroglucinols from Rhizomes of Dryopteris crassirhizoma.

Authors:  Juan Wang; Yan-Tao Yan; Shen-Zhen Fu; Bing Peng; Lin-Lin Bao; Yan-Ling Zhang; Jing-Hong Hu; Zu-Ping Zeng; Dong-Hao Geng; Zeng-Ping Gao
Journal:  Molecules       Date:  2017-03-08       Impact factor: 4.411

9.  Studies on Isoniazid Derivatives through a Medicinal Chemistry Approach for the Identification of New Inhibitors of Urease and Inflammatory Markers.

Authors:  Fazila Rizvi; Majid Khan; Almas Jabeen; Hina Siddiqui; M Iqbal Choudhary
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

10.  N-monoarylacetothioureas as potent urease inhibitors: synthesis, SAR, and biological evaluation.

Authors:  Wei-Yi Li; Wei-Wei Ni; Ya-Xi Ye; Hai-Lian Fang; Xing-Ming Pan; Jie-Ling He; Tian-Li Zhou; Juan Yi; Shan-Shan Liu; Mi Zhou; Zhu-Ping Xiao; Hai-Liang Zhu
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.